Kiora Pharmaceuticals Balance Sheet Health
Financial Health criteria checks 6/6
Kiora Pharmaceuticals has a total shareholder equity of $33.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $40.8M and $7.7M respectively. Kiora Pharmaceuticals's EBIT is $6.3M making its interest coverage ratio -9.7. It has cash and short-term investments of $27.8M.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | -9.7x |
| Cash | US$27.82m |
| Equity | US$33.10m |
| Total liabilities | US$7.71m |
| Total assets | US$40.81m |
Recent financial health updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 7EY's short term assets ($31.8M) exceed its short term liabilities ($1.7M).
Long Term Liabilities: 7EY's short term assets ($31.8M) exceed its long term liabilities ($6.1M).
Debt to Equity History and Analysis
Debt Level: 7EY is debt free.
Reducing Debt: 7EY had no debt 5 years ago.
Debt Coverage: 7EY has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 7EY has no debt, therefore coverage of interest payments is not a concern.